BioSpace News Archive

Genetown

Pulmatrix Announces Pricing Of $15.2 Million Underwritten Public Offering

-Pulmatrix, Inc. announced the pricing of an underwritten public offering of an aggregate of 23,500,000 units.

March 29, 2018
·
3 min read
Policy

Marketwired: Mar 29, 2018 -- Novoheart Files Patent Application on Disease Modeling Based on Landmark Research Conducted During Second Contract with Global Pharma Partner

Novoheart is pleased to announce that it has filed a patent application on the use of its proprietary MyHeart™ Platform of human bioengineered heart tissues to create disease models for neurological diseases in which afflicted patients suffer and often die from cardiac dysfunction.

March 29, 2018
·
3 min read
Business

Luye Pharma: A Healthy Thirty Percent Annual Growth Rate, with Competitive Product Pipelines across Different Therapeutic Areas

Luye Pharma (02186. HK), released its annual results on March 26, 2018.

March 29, 2018
·
5 min read
Business

EmpiRx Health Announces Karthik Ganesh as Executive Vice President and Chief Operating Officer

Karthik adds a new dimension to the company that will allow for the execution of key priorities enabling EmpiRx Health to achieve its vision.

March 29, 2018
·
3 min read
FDA

Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

SRK-015 is an inhibitor of the activation of myostatin, which Scholar Rock believes has the potential to be the first muscle-directed therapy to reverse or prevent muscle atrophy in SMA patients.

March 29, 2018
·
5 min read
Genetown

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

Biostage, Inc. announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD).

March 29, 2018
·
2 min read
Deals

Genprex Announces Pricing of Initial Public Offering of Common Stock

Genprex, Inc. announced the pricing of its initial public offering on March 28, 2018 of an aggregate of 1,280,000 shares of common stock at a public offering price of $5.00 per share, before underwriting discounts.

March 29, 2018
·
2 min read
Drug Development

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

Abbott announced today the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS™ HF System.

March 29, 2018
·
3 min read
Biotech Beach

Inari Medical Announces Completion of $27 Million Series C Financing

Inari Medical, Inc. announced today the close of a Series C financing totaling $27.0 million.

March 29, 2018
·
2 min read
Deals

JXTGE Announces Sale of Irvine Scientific to FujiFilm

JXTG Nippon Oil & Energy Corporation has announced it has agreed to sell Irvine Scientific Sales Company, Inc. and IS Japan Co., Ltd. to FUJIFILM Corporation (FujiFilm).

March 29, 2018
·
3 min read